Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Dorn

Showing results (51-60 of 393) with videos related to

Pageof 40
Sort By:
Current Opinion in Cardiology|April 6, 2011
Genetics of common forms of heart failureGerald W Dorn
Journal of Cardiovascular Pharmacology|February 2, 2011
MicroRNAs: redefining mechanisms in cardiac diseaseGerald W Dorn
Circulation Research|January 17, 2015
Gone fission…: diverse consequences of cardiac Drp1 deficiencyGerald W Dorn
Nature Reviews. Cardiology|April 9, 2009
Novel pharmacotherapies to abrogate postinfarction ventricular remodelingGerald W Dorn
Cell Metabolism|May 10, 2007
Myocardial angiogenesis: its absence makes the growing heart founderGerald W Dorn
Physiological Reviews|July 29, 2010
Adrenergic signaling polymorphisms and their impact on cardiovascular diseaseGerald W Dorn
Current Cardiology Reports|April 29, 2010
Therapeutic potential of microRNAs in heart failureGerald W Dorn
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2013
Mitochondrial dynamism and cardiac fate--a personal perspectiveGerald W Dorn
The American Journal of Physiology|July 1, 1991
Tissue- and species-specific differences in ligand binding to thromboxane A2 receptorsG W Dorn
Bulletin. American Pharmaceutical Association. Committee on National Formulary|March 19, 2010
Protein hydrolyzatesH W DORN
Pageof 40

Showing results (51-60 of 393) with videos related to

Sort By:
Pageof 40
Current Opinion in Cardiology|April 6, 2011
Genetics of common forms of heart failureGerald W Dorn
Journal of Cardiovascular Pharmacology|February 2, 2011
MicroRNAs: redefining mechanisms in cardiac diseaseGerald W Dorn
Circulation Research|January 17, 2015
Gone fission…: diverse consequences of cardiac Drp1 deficiencyGerald W Dorn
Nature Reviews. Cardiology|April 9, 2009
Novel pharmacotherapies to abrogate postinfarction ventricular remodelingGerald W Dorn
Cell Metabolism|May 10, 2007
Myocardial angiogenesis: its absence makes the growing heart founderGerald W Dorn
Physiological Reviews|July 29, 2010
Adrenergic signaling polymorphisms and their impact on cardiovascular diseaseGerald W Dorn
Current Cardiology Reports|April 29, 2010
Therapeutic potential of microRNAs in heart failureGerald W Dorn
Circulation Journal : Official Journal of the Japanese Circulation Society|April 26, 2013
Mitochondrial dynamism and cardiac fate--a personal perspectiveGerald W Dorn
The American Journal of Physiology|July 1, 1991
Tissue- and species-specific differences in ligand binding to thromboxane A2 receptorsG W Dorn
Bulletin. American Pharmaceutical Association. Committee on National Formulary|March 19, 2010
Protein hydrolyzatesH W DORN
Pageof 40